NCT02698007View on ClinicalTrials.gov

Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Respiratory Disease Undergoing Elective Bronchoscopy.Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Laryngeal Mask Airway (LMA)

Fiberoptic bronchoscopy with the use of LMA

Trial Locations (1)

49100

Pulmonary Institute,Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT02698007 - Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy | Biotech Hunter | Biotech Hunter